Harbour Investments Inc. Lowers Stock Position in iShares Biotechnology ETF $IBB

Harbour Investments Inc. lowered its position in iShares Biotechnology ETF (NASDAQ:IBB) by 13.6% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,600 shares of the financial services provider’s stock after selling 252 shares during the period. Harbour Investments Inc.’s holdings in iShares Biotechnology ETF were worth $202,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Ramirez Asset Management Inc. purchased a new stake in iShares Biotechnology ETF during the first quarter worth about $26,000. Berkshire Money Management Inc. purchased a new position in shares of iShares Biotechnology ETF in the second quarter worth about $28,000. Financial Gravity Asset Management Inc. bought a new position in shares of iShares Biotechnology ETF in the first quarter valued at approximately $30,000. Woodside Wealth Management LLC bought a new position in shares of iShares Biotechnology ETF in the first quarter valued at approximately $31,000. Finally, Trust Co. of Toledo NA OH bought a new stake in iShares Biotechnology ETF during the second quarter valued at approximately $32,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Down 1.4%

Shares of NASDAQ IBB opened at $153.92 on Thursday. iShares Biotechnology ETF has a 52 week low of $107.43 and a 52 week high of $157.19. The firm’s fifty day moving average is $144.20 and its 200 day moving average is $132.09.

iShares Biotechnology ETF Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, September 19th. Stockholders of record on Tuesday, September 16th were issued a dividend of $0.0828 per share. This represents a $0.33 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date was Tuesday, September 16th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.